Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis
- PMID: 31405902
- PMCID: PMC6689820
- DOI: 10.1136/bmj.l4563
Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis
Abstract
Objective: To determine any changes in total hospital revisits within 30 days of discharge after a hospital stay for medical conditions targeted by the Hospital Readmissions Reduction Program (HRRP).
Design: Retrospective cohort study.
Setting: Hospital stays among Medicare patients for heart failure, acute myocardial infarction, or pneumonia between 1 January 2012 and 1 October 2015.
Participants: Medicare fee-for-service patients aged 65 or over.
Main outcomes: Total hospital revisits within 30 days of discharge after hospital stays for medical conditions targeted by the HRRP, and by type of revisit: treat-and-discharge visit to an emergency department, observation stay (not leading to inpatient readmission), and inpatient readmission. Patient subgroups (age, sex, race) were also evaluated for each type of revisit.
Results: Our study cohort included 3 038 740 total index hospital stays from January 2012 to September 2015: 1 357 620 for heart failure, 634 795 for acute myocardial infarction, and 1 046 325 for pneumonia. Counting all revisits after discharge, the total number of hospital revisits per 100 patient discharges for target conditions increased across the study period (monthly increase 0.023 visits per 100 patient discharges (95% confidence interval 0.010 to 0.035)). This change was due to monthly increases in treat-and-discharge visits to an emergency department (0.023 (0.015 to 0.032) and observation stays (0.022 (0.020 to 0.025)), which were only partly offset by declines in readmissions (-0.023 (-0.035 to -0.012)). Increases in observation stay use were more pronounced among non-white patients than white patients. No significant change was seen in mortality within 30 days of discharge for target conditions (-0.0034 (-0.012 to 0.0054)).
Conclusions: In the United States, total hospital revisits within 30 days of discharge for conditions targeted by the HRRP increased across the study period. This increase was due to a rise in post-discharge emergency department visits and observation stays, which exceeded the decline in readmissions. Although reductions in readmissions have been attributed to improvements in discharge planning and care transitions, our findings suggest that these declines could instead be because hospitals and clinicians have intensified efforts to treat patients who return to a hospital within 30 days of discharge in emergency departments and as observation stays.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; RKW receives research support from the National Heart, Lung, and Blood Institute (1K23HL148525-1), and has previously served as consultant for Regeneron, outside the submitted work; KEJM receives research support from the National Heart, Lung, and Blood Institute (R01HL143421), National Institute on Aging (R01AG060935), and Commonwealth Fund; RWY receives research support from the National Heart, Lung and Blood Institute (R01HL136708) and the Richard A and Susan F Smith Center for Outcomes Research in Cardiology and received from Abiomed, personal fees from Asahi Intecc, grants from AstraZeneca, grants and personal fees from Boston Scientific, personal fees from Medtronic, and personal fees from Teleflex outside the submitted work; DSK receives research support from the Richard A and Susan F Smith Center for Outcomes Research in Cardiology; the other authors report no conflicts; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.
Figures


Similar articles
-
Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States.BMJ. 2020 Jan 15;368:l6831. doi: 10.1136/bmj.l6831. BMJ. 2020. PMID: 31941686 Free PMC article.
-
Assessment of Hospital Readmissions From the Emergency Department After Implementation of Medicare's Hospital Readmissions Reduction Program.JAMA Netw Open. 2020 May 1;3(5):e203857. doi: 10.1001/jamanetworkopen.2020.3857. JAMA Netw Open. 2020. PMID: 32356883 Free PMC article.
-
Outcomes after observation stays among older adult Medicare beneficiaries in the USA: retrospective cohort study.BMJ. 2017 Jun 20;357:j2616. doi: 10.1136/bmj.j2616. BMJ. 2017. PMID: 28634181 Free PMC article.
-
The Hospital Readmissions Reduction Program-learning from failure of a healthcare policy.Eur J Heart Fail. 2018 Aug;20(8):1169-1174. doi: 10.1002/ejhf.1212. Epub 2018 May 23. Eur J Heart Fail. 2018. PMID: 29791084 Free PMC article. Review.
-
Impact of Hospital Readmissions Reduction Program Policy on 30-Day and 90-Day Readmissions in Patients With Acute Myocardial Infarction: A 10-Year Trend From the National Readmissions Database.Curr Probl Cardiol. 2023 Jul;48(7):101696. doi: 10.1016/j.cpcardiol.2023.101696. Epub 2023 Mar 14. Curr Probl Cardiol. 2023. PMID: 36921652 Review.
Cited by
-
Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program.BMC Health Serv Res. 2021 Apr 26;21(1):386. doi: 10.1186/s12913-021-06399-z. BMC Health Serv Res. 2021. PMID: 33902569 Free PMC article.
-
Association between Medicare's Hospital Readmission Reduction Program and readmission rates across hospitals by medicare bed share.BMC Health Serv Res. 2021 Mar 19;21(1):248. doi: 10.1186/s12913-021-06253-2. BMC Health Serv Res. 2021. PMID: 33740969 Free PMC article.
-
Readmission After ACS: Burden, Epidemiology, and Mitigation.Curr Cardiol Rep. 2022 Jul;24(7):807-815. doi: 10.1007/s11886-022-01702-8. Epub 2022 Apr 30. Curr Cardiol Rep. 2022. PMID: 35488946 Review.
-
Emergency Department and Observation Revisits and the Hospital Readmission Reduction Program.JAMA Netw Open. 2025 Jul 1;8(7):e2524135. doi: 10.1001/jamanetworkopen.2025.24135. JAMA Netw Open. 2025. PMID: 40736737 Free PMC article.
-
Clinical and financial implications of inpatient and outpatient management of worsening heart failure.Eur J Heart Fail. 2025 May 26:10.1002/ejhf.3702. doi: 10.1002/ejhf.3702. Online ahead of print. Eur J Heart Fail. 2025. PMID: 40419411
References
-
- Hospital Readmissions Reduction Program (HRRP) Centers for Medicare and Medicaid Services. 2019 https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpat... accessed February 12 2019.
-
- 2017 Readmission Measures Updates and Specifications Report: Centers for Medicare & Medicaid Services (CMS); http://www.qualitynet.org/dcs/ContentServer?cid=1228774371008&pagename=Q... accessed February 2 2019.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases